

"Translating science into strategy and strategy into market leading healthcare brands"
Lucid Group fuses scientific rigour, behavioural insight and strategic foresight to transform healthcare communications. The firm partners with pharmaceutical and biotechnology companies across the asset lifecycle, delivering strategy consulting, medical communications and commercial execution. With over 500 specialists globally, Lucid has shaped more than 50 first in class therapies and supported over 100 launches. Lucid serves six of the top ten global pharmaceutical brands, applying therapeutic depth and AI tools to accelerate adoption. The firm translates complex science into stakeholder belief and market impact. Backed by private equity since 2017, Lucid redefines healthcare communications.


500
Team Members
2007
Founded
Consulting
Sector
Hybrid
Work Environment
A world where complex science transforms into clear stakeholder belief, driving confident decisions that accelerate life changing therapies from development through market adoption and lasting patient impact.
Lucid Group transforms lives by fusing scientific expertise, behavioural insight and strategic foresight to help pharmaceutical brands translate complex science into stakeholder belief, accelerate adoption and deliver meaningful patient outcomes.